Hundreds of lawsuits are currently pending in a multidistrict litigation against pharmaceutical company Sanofi-Aventis, over its breast cancer chemotherapy drug, Taxotere. Plaintiffs allege the company failed to warn them of the risk of permanent hair loss caused by the drug.